Lindane ban
This article was originally published in The Tan Sheet
Executive Summary
Rx head lice remedy banned in California as Gov. Gray Davis signs bill into law Sept. 5. Effective Jan. 1, 2002, the bill prohibits the sale or use of the drug to treat head lice or scabies, but permits ingredient's use as an industrial pesticide. Assemblyman Alan Lowenthal (D) and other lawmakers pushed the measure based on concerns of neurotoxicity and carcinogenicity. The journal Contemporary Pediatrics recently voiced the support of the medical community for the use of OTC head lice treatments as the first line of defense and specifically advised against the use of lindane (1"The Tan Sheet" Sept. 11, In Brief)
You may also be interested in...
Lice
First-line treatment should be a pyrethrin- or permethrin-containing OTC, a supplement to the August issue of Contemporary Pediatrics advises. "Guidelines for the treatment of resistant pediculosis" suggest growing resistance of head lice to OTC preparations should not discourage parents and health care professionals from using products containing those ingredients - such as Bayer's Rid and Pfizer's Nix - to treat head lice infestations in children. Rx treatments, such as malathion, should be considered second-line therapy except in regions with high resistance to OTC pediculicides; lindane-containing Rx products should be the last resort due to toxicity concerns, the guidelines assert
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands